新股配售 | 兆科眼科-B一手中籤率25%，公開認購56倍，國配5.3倍，有綠鞋
uSMART盈立智投4月28日消息，兆科眼科-B今日公佈中籤結果，並將於今日16:15-18:30進行暗盤交易。
【配售小結】
①冷：新股市場跟隨全球二級市場"倒春寒"，即便有高瓴作爲股東，有GIC作爲基石，兆科眼科-B的申購人數約11.1萬，比二次上市中概股熱，但比新股狂熱時期繼續大幅回落。公開認購倍數56倍，回撥比例提高，最終公開佔比40%，國配佔比60%。
②有綠鞋：國際發售中超額分配18,535,000股股份，有15%的綠鞋子彈，穩價人系高盛，倘若新股首日情緒不佳，穩價人護盤，對於股價能起到一定的穩定作用，但是回撥給公開越多，這個作用就越發微弱。
③乙組打和點低：乙組中籤市值約爲42.8萬-788.8萬港元，整體打和點約1.8%左右。
【配售簡況】
1、發行價：16.8港元，爲招股價區間(15.38-16.8港元)的上限
2、一手市值：8400港元，每手500股
3、有效申購人數：111,183名(甲組：110,672名，乙組：511名)
4、實際中籤人數：41,656名
5、中籤情況：一手中籤率25%，申購10手穩中1手，甲尾中6手，乙頭中51手，頂頭槌中939手
6、公開認購倍數：56倍(甲組：63倍，乙組：49倍)
7、國際發售：認購倍數約5.3倍，合共110名承配人，現股東高瓴認購115萬股，前25名承配人合共鎖定66.17%的發行股份
8、回撥情況：有回撥，最終公開佔比40%，國配佔比60%
9、優先發售：認購倍數約1.2倍
10、基石投資者：GIC、奧博資本等8名基石投資者合共鎖定20.6%的發行股份，禁售期6個月
11、超額配股權：國際發售中超額分配18,535,000股股份，有綠鞋
12、穩定價格操作人：高盛，穩價結束日爲2021年5月21日
13、uSMART盈立智投暗盤交易時段：4月28日16:15-18:30
【中籤分配基準】
【優先發售的分配基準】
【基石投資者】
【禁售承諾】
【股權集中度分析】
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
